Literature DB >> 11273647

The metabolism and imaging in live cells of the bovine prion protein in its native form or carrying single amino acid substitutions.

A Negro1, C Ballarin, A Bertoli, M L Massimino, M C Sorgato.   

Abstract

Prion diseases are probably caused by an abnormal form of a cellular glycoprotein, the prion protein. Recent evidence suggests that the prion strain causing BSE has been transmitted to humans, thereby provoking a variant form of Creutzfeldt-Jacob disease. In this work, we analyzed the behavior of normal and malformed isoforms of the bovine PrP in transfected mammalian cell lines. Biochemical and immunocytochemical assays were complimented with imaging of live cells expressing fusion constructs between PrP and GFP. Bovine homologues of human E200K and D178N (129M) mutations were used as models of pathogenic isoforms. We show that the GFP does not impair the metabolism of native and mutant bPrPs and is thus a valid marker of PrP cellular distribution. We also show that each amino acid replacement provokes alterations in the cell sorting and processing of bPrP. These are different from those ascribed to both murine mutant homologues. However, human and bovine PrPs carrying the D178N genotype had similar cellular behavior. Copyright 2001 Academic Press.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11273647     DOI: 10.1006/mcne.2000.0953

Source DB:  PubMed          Journal:  Mol Cell Neurosci        ISSN: 1044-7431            Impact factor:   4.314


  11 in total

1.  The 'BSE Strategic Project' of the National Council of Research: results of four years of research.

Authors:  F Valfrè; V M Moretti
Journal:  Vet Res Commun       Date:  2003-09       Impact factor: 2.459

2.  Mutant prion protein expression is associated with an alteration of the Rab GDP dissociation inhibitor alpha (GDI)/Rab11 pathway.

Authors:  Tania Massignan; Emiliano Biasini; Eliana Lauranzano; Pietro Veglianese; Mauro Pignataro; Luana Fioriti; David A Harris; Mario Salmona; Roberto Chiesa; Valentina Bonetto
Journal:  Mol Cell Proteomics       Date:  2009-12-07       Impact factor: 5.911

Review 3.  Molecular advances in understanding inherited prion diseases.

Authors:  David R Brown
Journal:  Mol Neurobiol       Date:  2002-06       Impact factor: 5.590

4.  Hyperbaric oxygen enhances the expression of prion protein and heat shock protein 70 in a mouse neuroblastoma cell line.

Authors:  Woei-Cherng Shyu; Shinn-Zong Lin; Keiichi Saeki; Astsutaka Kubosaki; Yoshitsugu Matsumoto; Takashi Onodera; Ming-Fu Chiang; Peterus Thajeb; Hung Li
Journal:  Cell Mol Neurobiol       Date:  2004-04       Impact factor: 5.046

5.  Caspase-12 and endoplasmic reticulum stress mediate neurotoxicity of pathological prion protein.

Authors:  Claudio Hetz; Milene Russelakis-Carneiro; Kinsey Maundrell; Joaquin Castilla; Claudio Soto
Journal:  EMBO J       Date:  2003-10-15       Impact factor: 11.598

6.  The prion protein and its paralogue Doppel affect calcium signaling in Chinese hamster ovary cells.

Authors:  Marisa Brini; Manuela Miuzzo; Nicola Pierobon; Alessandro Negro; Maria Catia Sorgato
Journal:  Mol Biol Cell       Date:  2005-03-23       Impact factor: 4.138

7.  Compartment-restricted biotinylation reveals novel features of prion protein metabolism in vivo.

Authors:  Amy B Emerman; Zai-Rong Zhang; Oishee Chakrabarti; Ramanujan S Hegde
Journal:  Mol Biol Cell       Date:  2010-10-27       Impact factor: 4.138

8.  Selective processing and metabolism of disease-causing mutant prion proteins.

Authors:  Aarthi Ashok; Ramanujan S Hegde
Journal:  PLoS Pathog       Date:  2009-06-19       Impact factor: 6.823

9.  Cellular prion protein and caveolin-1 interaction in a neuronal cell line precedes Fyn/Erk 1/2 signal transduction.

Authors:  Mattia Toni; Enzo Spisni; Cristiana Griffoni; Spartaco Santi; Massimo Riccio; Patrizia Lenaz; Vittorio Tomasi
Journal:  J Biomed Biotechnol       Date:  2006

10.  Prion Protein Protects against Renal Ischemia/Reperfusion Injury.

Authors:  Bo Zhang; Daniel Cowden; Fan Zhang; Jue Yuan; Sandra Siedlak; Mai Abouelsaad; Liang Zeng; Xuefeng Zhou; John O'Toole; Alvin S Das; Diane Kofskey; Miriam Warren; Zehua Bian; Yuqi Cui; Tao Tan; Adam Kresak; Robert E Wyza; Robert B Petersen; Gong-Xian Wang; Qingzhong Kong; Xinglong Wang; John Sedor; Xiongwei Zhu; Hua Zhu; Wen-Quan Zou
Journal:  PLoS One       Date:  2015-09-01       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.